Tag Archives: market access

Veradigm and CareMetx Partner to Optimize Specialty Medication Access

Many hub service providers and other companies develop patient support platforms to offer patient-centric capabilities in order to provide better services that improve patient outcomes

Phil, Inc. Disrupting Traditional Hub Services Provider Market

A number of innovative companies have entered the increasingly competitive traditional specialty pharmaceutical Hub services market

Indegene Acquires Medical Marketing Economics (MME)

Indegene has acquired market-access advisory Medical Marketing Economics (MME) for $10 million, as it seeks to bolster its biopharma pricing and reimbursement capabilities

EVERSANA Partners With Resverlogix to Commercialize Breakthrough Cardiovascular/CKD drug

In preparation for launch, Resverlogix will utilize EVERSANA’s fully integrated commercialization services

Genentech (Roche) and Blueprint Medicines Collaborate to Increase Market Access

Both Gavreto and AYVAKIT are available through Blueprint’s specialty distribution network and two specialty pharmacies: Biologics by McKesson and PantherRx

Tanner Pharma Group Increasing Product Access With Named Patient Programs

A Named Patient Program (NPP) provides patients and physicians access to commercially approved medicines that are not available to them in their own country

Amplity Health Growing in Pharmaceutical Commercialization Market

Amplity Health looking to grow in pharmaceutical commercialization market with support of Altamont Capital Partners

Market Access Programs for Gene Therapies Increasing

Payers are planning for an increasing number of gene therapies being approved by developing new coverage programs